Skip to:Content
|
Bottom
Cover image for Phage display In biotechnology and drug discovery
Title:
Phage display In biotechnology and drug discovery
Series:
Drug discovery series /3
Publication Information:
Boca Raton, FL : CRC Press, 2005
Physical Description:
xviii, 748 p. : ill. ; 24 cm.
ISBN:
9780824754662
Added Author:

Available:*

Library
Item Barcode
Call Number
Material Type
Item Category 1
Status
Searching...
30000010230343 QR342 P424 2005 Open Access Book Book
Searching...

On Order

Summary

Summary

The first and only guide to showcase the impact of phage display technology on drug discovery, this reference details the theories, principles, and methods impacting the field and demonstrates applications for peptide phage display, protein phage display, and the development of novel antibodies. Highlighting the current and future role of phage display in the development of protein therapeutics, this book provides a comprehensive overview that will prove invaluable to anyone researching recombinant antibodies.

Daniel E. Levy, editor of the Drug Discovery Series, is the founder of DEL BioPharma, a consulting service for drug discovery programs. He also maintains a blog that explores organic chemistry.


Table of Contents

James A. WellsDiane J. Rodi and Suneeta Mandava and Lee MakowskiValery A. Petrenko and George P. SmithFrederic A. Fellouse and Gabor PalMark S. DennisNienke E. Van Houten and Jamie K. ScottKurt DeshayesShuichi OhkuboZhaozhong Han and Ece Karatan and Brian K. KayRobert O. Carlson and Robin Hyde-DeRuyscher and Paul T. HamiltonMihriban Tuna and Derek N. WoolfsonReto Crameri and Claudio Rhyner and Michael Weichel and Sabine Fluckiger and Zoltan KonthurSara K. Avrantinis and Gregory A. WeissJulian Bertschinger and Christian Heinis and Dario NeriJonathan S. Marvin and Henry B. LowmanJody D. Berry and Mikhail PopkovClaire L. Dobson and Ralph R. Minter and Celia P. Hart-ShorrockFrederic A. Fellouse and Sachdev S. Sidhu
Forewordp. v
Prefacep. vii
Contributorsp. xv
1 Filamentous Bacteriophage Structure and Biologyp. 1
I Introductionp. 1
II Taxonomy and Geneticsp. 3
III Viral Gene Productsp. 5
IV Structure of the Virionp. 11
V Filamentous Bacteriophage Life Cyclep. 18
VI Phage Library Diversityp. 34
VII Biological Bottlenecks: Sources of Library Censorshipp. 35
VIII Quantitative Diversity Estimationp. 41
IX Improved Library Constructionp. 45
Referencesp. 47
2 Vectors and Modes of Displayp. 63
I Introductionp. 63
II Most Display Vectors are Based on Filamentous Phagep. 65
III General Cloning Vectors Based on Filamentous Phagep. 71
IV Classification of Filamentous Phage Display Systemsp. 75
V Phage f1-The First Phage-Display Vectorp. 77
VI Low DNA Copy Number Display Vectors Based on fd-tetp. 78
VII Diversity of Type 3 Vectorsp. 80
VIII Type 8 Vectors: First Lessonsp. 81
IX Mosaic Display in Type nn Systemsp. 83
X Mosaic Display in Phagemid Systemsp. 89
XI Vectors for C-Terminal Displayp. 91
XII Phage Proteins as Constraining Scaffoldsp. 93
XIII Conclusionp. 95
Referencesp. 98
3 Methods for the Construction of Phage-Displayed Librariesp. 111
I Introductionp. 111
II Oligonucleotide-Directed Mutagenesisp. 112
III Random Mutagenesisp. 123
IV Combinatorial Infection and Recombinationp. 126
V DNA Shufflingp. 129
Referencesp. 135
4 Selection and Screening Strategiesp. 143
I Introductionp. 143
II General Considerationsp. 144
III The Selection Processp. 146
IV Selections Methodsp. 150
Referencesp. 161
5 Phage Libraries for Developing Antibody-Targeted Diagnostics and Vaccinesp. 165
I Introductionp. 165
II Phage-Display Libraries as Tools for Epitope Discoveryp. 170
III Diagnosticsp. 179
IV Phage Libraries for Epitope Mappingp. 187
V Phage Display Libraries for Vaccine Developmentp. 200
VI Developing Immunogens from Peptide Leadsp. 218
VII Summaryp. 235
VIII Conclusionp. 238
IX Abbreviationsp. 239
Referencesp. 240
6 Exploring Protein-Protein Interactions Using Peptide Libraries Displayed on Phagep. 255
I Introductionp. 255
II Extracellular Protein-Protein Interactionsp. 256
III Intracellular Protein-Protein Interactionsp. 268
IV Conclusionsp. 274
Referencesp. 275
7 Substrate Phage Displayp. 283
I Overviewp. 283
II Introductionp. 284
III The Concept of Substrate Phage Displayp. 285
IV Application of Substrate Phage Display to Cancer Researchp. 294
V Conclusionsp. 305
Referencesp. 308
8 Mapping Intracellular Protein Networksp. 321
I Introductionp. 321
II Domain-Mediated Interactionsp. 323
III Nondomain Mediated Protein-Protein Interactionsp. 336
IV Software for Identifying Candidate Interacting Partnersp. 336
V Analyzing Predicted Interactionsp. 337
VI Relevance to Biotechnology and Drug Discoveryp. 338
Referencesp. 340
9 High Throughput and High Content Screening Using Peptidesp. 347
I Introductionp. 347
II Peptides as Enzyme Inhibitorsp. 348
III Peptides as Conformational Probesp. 355
IV Summaryp. 376
Referencesp. 377
10 Engineering Protein Folding and Stabilityp. 385
I Protein Redesign and Designp. 385
II Early Combinatorial Studies Aimed at Repacking the Cores of Proteinsp. 387
III Phage Display in Engineering Protein Stabilityp. 390
IV A Worked Example: Repacking the Hydrophobic Core of Ubiquitinp. 397
V Studies that Build on the Original Methodsp. 406
VI Summaryp. 408
Referencesp. 409
11 Identification of Natural Protein-Protein Interactions with cDNA Librariesp. 415
I Overviewp. 415
II Introductionp. 416
III Cloning Vectorsp. 417
IV Display of cDNA Libraries on Phage Surfacep. 420
V Problems Associated with the Display of cDNA Libraries on Phage Surfacep. 425
VI Adaptability of Phage Display to High-Throughput Screening Technologyp. 427
VII Conclusionsp. 428
Referencesp. 429
12 Mapping Protein Functional Epitopesp. 441
I Introductionp. 441
II Single Point Alanine Mutagenesisp. 443
III Combinatorial Site-Specific Mutagenesisp. 447
IV Other Approaches to Phage-Displayed Functional Epitope Mappingp. 455
V Conclusionp. 456
Referencesp. 456
13 Selections for Enzymatic Catalystsp. 461
I Introductionp. 461
II Selection Methodsp. 464
III Discussionp. 482
Referencesp. 486
14 Antibody Humanization and Affinity Maturation Using Phage Displayp. 493
I Introductionp. 493
II Humanization Using Phage Displayp. 497
III In Vitro Affinity Maturation of Antibodiesp. 501
IV Emerging Approachesp. 519
V Conclusionsp. 520
Referencesp. 521
15 Antibody Libraries from Immunized Repertoiresp. 529
I Introductionp. 529
II Immune Antibody Library Constructionp. 538
III Immune Antibody Library Selectionp. 570
IV The Futurep. 622
Referencesp. 624
16 Naive Antibody Libraries from Natural Repertoiresp. 659
I Introductionp. 659
II Construction of Naive Librariesp. 660
III Applications of Naive Librariesp. 674
IV Summaryp. 700
Referencesp. 700
17 Synthetic Antibody Librariesp. 709
I Introductionp. 709
II The Scripps Research Institutep. 711
III The Medical Research Councilp. 714
IV Morphosysp. 720
V Genentechp. 726
VI Conclusionsp. 732
Referencesp. 733
Indexp. 741
Go to:Top of Page